Phase 2a study shows improved vision with stem cell therapy for retinitis pigmentosa
VANCOUVER, British Columbia — Human retinal progenitor cell therapy from ReNeuron Group is showing positive preliminary results in the company’s ongoing phase 1/2a clinical trial involving patients with retinitis pigmentosa.…